IAC regimen

	WikiDoc Resources for IAC regimen
Articles
Most recent articles on IAC regimen Most cited articles on IAC regimen Review articles on IAC regimen Articles on IAC regimen in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on IAC regimen Images of IAC regimen Photos of IAC regimen Podcasts & MP3s on IAC regimen Videos on IAC regimen
Evidence Based Medicine
Cochrane Collaboration on IAC regimen Bandolier on IAC regimen TRIP on IAC regimen
Clinical Trials
Ongoing Trials on IAC regimen at Clinical Trials.gov Trial results on IAC regimen Clinical Trials on IAC regimen at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on IAC regimen NICE Guidance on IAC regimen NHS PRODIGY Guidance FDA on IAC regimen CDC on IAC regimen
Books
Books on IAC regimen
News
IAC regimen in the news Be alerted to news on IAC regimen News trends on IAC regimen
Commentary
Blogs on IAC regimen
Definitions
Definitions of IAC regimen
Patient Resources / Community
Patient resources on IAC regimen Discussion groups on IAC regimen Patient Handouts on IAC regimen Directions to Hospitals Treating IAC regimen Risk calculators and risk factors for IAC regimen
Healthcare Provider Resources
Symptoms of IAC regimen Causes & Risk Factors for IAC regimen Diagnostic studies for IAC regimen Treatment of IAC regimen
Continuing Medical Education (CME)
CME Programs on IAC regimen
International
IAC regimen en Espanol IAC regimen en Francais
Business
IAC regimen in the Marketplace Patents on IAC regimen
Experimental / Informatics
List of terms related to IAC regimen

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aparna Vuppala, M.B.B.S. [2]

Synonyms and keywords: Idarubicin-Ara C-Cladribine regimen; Idarubicin-Cytarabine-Cladribine regimen

Overview[edit | edit source]

IAC regimen refers to a regimen consisting of idarubicin, cytarabine (Ara-C), and cladribine used to treat acute myelogenous leukemia.^[1]

Regimen[edit | edit source]

IIdrarubicin

ACytarabine (Ara-C)

CCladribin

Indications[edit | edit source]

Acute myelogenous leukemia^[1]

References[edit | edit source]

↑ ^1.0 ^1.1 Juliusson G, Höglund M, Karlsson K, Löfgren C, Möllgård L, Paul C; et al. (2003). "Increased remissions from one course for intermediate-dose cytosine arabinoside and idarubicin in elderly acute myeloid leukaemia when combined with cladribine. A randomized population-based phase II study". Br J Haematol. 123 (5): 810–8. PMID 14632771.

[pmid14632771-1] 1.0 ^1.1 Juliusson G, Höglund M, Karlsson K, Löfgren C, Möllgård L, Paul C; et al. (2003). "Increased remissions from one course for intermediate-dose cytosine arabinoside and idarubicin in elderly acute myeloid leukaemia when combined with cladribine. A randomized population-based phase II study". Br J Haematol. 123 (5): 810–8. PMID 14632771.

[1]